Effectively, MSI-H tumors express higher levels of tumor-infiltrating lymphocytes (TILs), cytotoxic T-lymphocyte-associated protein 4 (CTLA4), programmed cell death 1 (PD1)/PD-ligand 1 (PD-L1), indoleamine 2,3-dioxygenase (IDO), and lymphocyte-activation gene 3 (LAG-3) [28]. This evidence concerns the gene PDCD1 and neoplasm.